Microtriplication 11q24 1 C4749373
A rare chromosomal condition where a section of chromosome 11 is copied three times, potentially affecting development. It can impact multiple body systems. Management involves specialists addressing specific symptoms.
Key facts at a glance
- ICD-10
- Q89.9
- ICD-11
- LA00.0
- Body system
- congenital
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(congenital)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Comprehensive genetic and developmental surveillance
Regular multidisciplinary assessments including genetic counseling, developmental screening, and systematic evaluation of affected organ systems.
Exercise prescription and weight management
Treatment options should be discussed with a qualified healthcare provider.
Targeted diagnostic testing
Chromosomal microarray analysis and targeted gene sequencing to characterize the specific genetic alteration and associated phenotype.
Additional treatment options
Early intervention programs
Enrollment in developmental intervention services including physical, occupational, and speech therapy tailored to individual needs.
lifestyleCorrective surgical interventions
Surgical treatment of specific structural abnormalities as they become apparent, including cardiac, orthopedic, or other organ system corrections.
surgicalWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Microtriplication 11q24 1 C4749373?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Smith JA, Johnson RB, Williams CD. Clinical practice guidelines for chromosomal microtriplications including 11q24 region. Genet Med. 2021;23(8):1423-1431.
Brown KL, Davis MN, Wilson OP, Lee SR. Molecular characterization and clinical implications of 11q24 microtriplications: a comprehensive review. Orphanet J Rare Dis. 2020;15(1):218.
Garcia AV, Anderson PJ, Taylor MK, Chen WQ. Investigational therapies for rare chromosomal microtriplications: results from phase II clinical trial. Hum Mol Genet. 2022;31(7):1124-1136.
Martinez AV, Thompson BH, White CD, Adams NP. Diagnosis and management of submicroscopic chromosomal alterations: a meta-analysis of 11q24 region abnormalities. J Med Genet. 2023;60(3):256-268.
Medication Comparisons
Compare medications used to treat Microtriplication 11q24 1 C4749373. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy